Success Metrics

Clinical Success Rate
88.9%

Based on 8 completed trials

Completion Rate
89%(8/9)
Active Trials
0(0%)
Results Posted
13%(1 trials)
Terminated
1(10%)

Phase Distribution

Ph phase_2
2
20%

Phase Distribution

0

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution2 total trials
Phase 2Efficacy & side effects
2(100.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Completed(8)
Terminated(1)
Other(1)

Detailed Status

Completed8
unknown1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
88.9%
Most Advanced
Phase 2

Trials by Phase

Phase 22 (100.0%)

Trials by Status

completed880%
unknown110%
terminated110%

Recent Activity

0 active trials
Showing 5 of 10
terminatedphase_2

RFT5-dgA Immunotoxin in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Non-Hodgkin Lymphoma

NCT00667017
completed

Biomarkers in Samples From Patients With Chronic Lymphocytic Leukemia Treated on Clinical Trial ECOG-2997

NCT00899873
completed

Biomarker Study in Tissue Samples From Patients With Acute Myeloid Leukemia

NCT01232842
completed

Cell Samples From Patients With Leukemia

NCT01395628
completed

Studying Biomarkers in Cell Samples From Young Patients With Acute Myeloid Leukemia

NCT01057290
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT00667017Phase 2

RFT5-dgA Immunotoxin in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Non-Hodgkin Lymphoma

Terminated
NCT00899873

Biomarkers in Samples From Patients With Chronic Lymphocytic Leukemia Treated on Clinical Trial ECOG-2997

Completed
NCT01232842

Biomarker Study in Tissue Samples From Patients With Acute Myeloid Leukemia

Completed
NCT01395628

Cell Samples From Patients With Leukemia

Completed
NCT01057290

Studying Biomarkers in Cell Samples From Young Patients With Acute Myeloid Leukemia

Completed
NCT00897338

Identifying Circulating Breast Cancer Cells in Women With Metastatic Breast Cancer

Completed
NCT00919997

Human Papilloma Virus Infection in HIV-Positive Indian Men Who Have Sex With Men

Completed
NCT01057199

Studying Biomarkers in Cell Samples From Patients With Acute Myeloid Leukemia

Completed
NCT01575535

S0106B Studying Bone Marrow Samples From Women With Acute Myeloid Leukemia

Completed
NCT00690872Phase 2

Gemcitabine and Carboplatin Followed By Laboratory-Treated T Lymphocytes in Treating Patients With Metastatic or Locally Recurrent Epstein-Barr Virus-Positive Nasopharyngeal Cancer

Unknown

All 10 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
10